IGF1 and neoplasm: In ESCC patients, tumour expression of IGF-1 RNA in the top versus the bottom quartile expression groups was associated with worse overall survival (OS) (HR, 1.876; 95% CI 1.2007 – 2.915, p = 0.005) (Fig. 3g).